Chinese Journal of Blood Purification ›› 2024, Vol. 23 ›› Issue (01): 1-8.doi: 10.3969/j.issn.1671-4091.2024.01.001

    Next Articles

Interpretation on the 2023 clinical practice guidelines of plasma component purification technology from the American Society for Apheresis (9th edition) 

WAN Li,  WANG Mei   

  1. Blood Purification Center, Department of Nephrology, Peking University International Hospital, Beijing 102206, China; 2Department of Nephrology, Peking University People's Hospital, Beijing 100044, China
  • Received:2023-08-22 Revised:2023-09-29 Online:2024-01-12 Published:2024-01-12
  • Contact: 100044 北京,2北京大学人民医院肾内科 E-mail:wangmei1949@163.com

Abstract:  In April 2023, the American Society for Apheresis (ASFA) released the 9th edition of guidelines for clinical practice of therapeutic apheresis. Based on published literature, these guidelines define the quality of evidence and the recommended strength of therapeutic apheresis in the treatment of diseases, and discuss the clinical application of therapeutic apheresis in 91 disease (166 indications). This article focuses on the interpretation of clinical multidisciplinary applications of plasma component purification technology, including plasma exchange and immuneadsorption.

Key words: Apheresis, Plasma exchange, Immunoadsorption, Clinical practice

CLC Number: